American Society of Addiction Medicine
American Society of Addiction Medicine
Lead: Medicaid Unwinding and Changes in Buprenorphine Dispensing
Lead: Medicaid Unwinding and Changes in Buprenorphine Dispensing
Lead: Medicaid Unwinding and Changes in Buprenorphine Dispensing
Wednesday 28th May 2025
Explore the impact of Medicaid changes on buprenorphine dispensing and discover new research in addiction medicine.
7 minutes
Informative
Eye-opening
Educational
Hopeful
Compassionate
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
178 (View all)
Do you want to link to this podcast?
Get the buttons here!Medicaid Changes & Buprenorphine: What's Happening?
Episode Overview
- Medicaid unwinding has led to disruptions in buprenorphine therapy.
- SBI810 offers a non-addictive alternative for pain management.
- Cannabis use may be linked to suicidality, independent of depression.
- Methamphetamine use is rising among patients with opioid use disorder.
- Transcranial magnetic stimulation shows promise for stimulant use disorders.
"Medicaid unwinding has been linked to disruptions in buprenorphine therapy, raising concerns about increased opioid-related risks".
Get ready to dive into the fascinating world of addiction medicine with 'This Week in Addiction Medicine' from ASAM. This episode kicks off with a deep dive into the effects of Medicaid unwinding on buprenorphine dispensing. You'll hear about a comprehensive study from JAMA Network Open that highlights how changes in Medicaid enrollment have led to disruptions in buprenorphine therapy, raising concerns about increased opioid-related risks.
This isn't just a dry data dump; it's an eye-opener about the real-world impact on patients who may be forced to turn to private insurance or cash for their prescriptions. The episode also touches on cutting-edge research in pain management with SBI810, a promising non-addictive alternative for treating pain, potentially reducing reliance on opioids. The conversation shifts gears to explore the complex relationship between cannabis use and suicidality, dissecting how depression might influence this link.
It's not all doom and gloom, though—there's hope in understanding these connections better. For those curious about stimulant use trends among patients with opioid use disorder, there's a fascinating segment on the rising use of methamphetamine and its implications. Plus, the episode covers intriguing studies on brain dynamics in heroin addiction recovery and the potential of repetitive transcranial magnetic stimulation for treating stimulant use disorders.
If you're keen to understand the nuanced interplay between addiction, mental health, and treatment innovations, this episode is a must-listen. It offers a blend of research insights and practical implications that could be vital for anyone affected by or interested in addiction medicine.